about
Early menopause: A hazard to a woman's healthEarly prophylactic treatment in pregnant women during the 2009-2010 H1N1 pandemic: obstetric and neonatal outcomes.Complications of hysteroscopic Essure(®) sterilisation: report on 4306 procedures performed in a single centre.Comprehensive clinical management of hirsutism.Further data favouring hormonal dependency of cerebral meningiomas: evidence from a patient treated with cabergoline.Tolerability of different oral iron supplements: a systematic review.Risk of hypoactive sexual desire disorder and associated factors in a cohort of oophorectomized women.The clinical relevance of the effect of ospemifene on symptoms of vulvar and vaginal atrophyOutpatient hysteroscopic polypectomy: bipolar energy system (Versapoint®) versus diode laser - randomized clinical trial.Management of post-menopausal vaginal atrophy and atrophic vaginitis.Available medical choices for the management of menopause.Effect of ospemifene on moderate or severe symptoms of vulvar and vaginal atrophyDefinition and diagnosis of sexuality in the XXI century.Tibolone inhibits aortic atherosclerotic lesionformation in oophorectomized cholesterol-fed rabbits.Efficacy of ossein-hydroxyapatite complex compared with calcium carbonate to prevent bone loss: a meta-analysis.The role of intranasal estradiol spray in the management of moderate to severe vasomotor symptoms in menopausal women.Therapeutic options for postmenopausal female sexual dysfunction.Periodontitis and osteoporosis: a systematic review.Menopause and aging: changes in the immune system--a review.Management of Turner's syndrome in adult life: case-series and systematic review.Evidence-based assessment of the impact of the WHI on women's health.Understanding weight gain at menopause.Phytoestrogens and bone health at different reproductive stages.The immune system and aging: a review.Spanish consensus on sexual health in men and women over 50.Use of ossein-hydroxyapatite complex in the prevention of bone loss: a review.Essure® and chronic pelvic pain: a population-based cohort.Management of Turner syndrome in adult life and beyond.Essure a novel option for the treatment of hydrosalpinx: a case series and literature review.Supplementation during pregnancy: beliefs and science.Cardiovascular risk in climacteric women: focus on diet.The relationships between mercury and selenium in plankton and fish from a tropical food web.Sexuality and quality of life in congenital hypogonadisms.Use of hormone therapy for menopausal symptoms and quality of life in breast cancer survivors. Safe and ethical?Vaginal misoprostol and cervical ripening balloon for induction of labor in late-term pregnancies.Vulvar and vaginal atrophy as viewed by the Spanish REVIVE participants: symptoms, management and treatment perceptions.Local hormone therapy for genitourinary syndrome of menopause in breast cancer patients: is it safe?Current knowledge of environmental exposure in children during the sensitive developmental periods.Patients' and clinicians' attitudes after the Women's Health Initiative study.Position of the Spanish Menopause Society regarding the management of menopausal symptoms in breast cancer patients.
P50
Q26744703-27392A95-A434-49DC-8AFB-B248DEA08353Q30427671-42252EF4-D804-4143-AC7A-25A0ABADDBE9Q33160999-3D818909-6B6B-4150-9DD1-FF7154B75E34Q33539381-FA830B32-1F5C-4251-8536-2ACE63006534Q33586465-4CDF79A8-64C1-4914-A04A-828214BEEAD1Q34517969-E0087F05-F6B2-4929-BCD6-E3BF2BE55B49Q35012367-2AA3E729-5C6B-4AE1-847F-E46EE3603599Q35626394-D988F29D-F500-40C1-A016-544823DA6E80Q35829966-2CCFC27B-98C7-463F-8C7F-4E929F8A3F55Q36247759-D2C69517-73F1-4091-AA78-5DDDA589F9A9Q36280624-9698C3F4-2D88-445F-B113-F105EE5B8E9FQ36482360-197DD489-F7AD-4244-9D26-8539631F91DCQ37121241-CD9DE9B9-8838-4302-ABAE-647B893FD22EQ37276381-5D2B0DB1-1401-49AD-BCCD-945F9E152F19Q37466196-856F019C-1FB8-4F7F-83A8-EF3169469140Q37565326-FCBC989A-FBFE-4547-9782-7605B6AE684EQ37643712-4F9C0348-D30A-49CF-BE85-D47EAC194869Q37778394-C8161F26-237A-429B-B130-E8648AB6BFB6Q37784916-560C520D-718B-4270-A206-D2B4B4876036Q37982456-2D5E8085-B0F2-46E0-90DC-AD96A383EAA5Q38011787-3258E840-CC4A-4A46-8B0A-FD84F13A3D72Q38043486-1CA1E785-74F4-4242-B8E6-B82C0D40A0D8Q38112453-C88DA7B3-9F0D-4E5A-B3D1-5533C224067BQ38161967-142E80A1-0ECB-440B-AB6F-7611944E7C45Q38203082-91EC52A0-5746-4D27-B2DC-D139E8200585Q38217340-E88B5391-6142-4013-A00B-A3312D86DB9DQ38218690-13B2FD31-C46C-4EEB-940F-4A02FDBE4FA9Q38273386-333F3888-9194-4FC3-B8B0-2D32701DCBF2Q38619258-F7814758-C704-434E-81BE-89D918E3C7D5Q38765995-3C287289-FCB3-4EF0-9A97-75A8C30D42F0Q38817221-210A4659-F566-4BB8-9ACA-D0F5CC32185AQ38974579-56898091-0615-468D-9512-B35E5E06934EQ38997462-00E58CEB-EE1B-42E2-BC8B-FB2A31626891Q39023481-CCA443CB-C813-46FB-A64C-C97981731DD8Q39120957-6C816F36-CAFB-4AD5-95AD-CFD25E553687Q39161834-1E727706-542B-43E7-BC9B-256E8B702740Q39170418-255CAE6F-D048-42D3-8E69-70A400BFF0DDQ39207929-501C24D8-786F-4220-AAD0-D5AABAE52EADQ39219345-940A8E0C-195A-4B30-8F5C-4084EAED1BFEQ39226759-51FD8ED4-7A27-4CE7-A3FF-1309428832B8
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Camil Castelo-Branco
@ast
Camil Castelo-Branco
@en
Camil Castelo-Branco
@es
Camil Castelo-Branco
@nl
Camil Castelo-Branco
@sl
type
label
Camil Castelo-Branco
@ast
Camil Castelo-Branco
@en
Camil Castelo-Branco
@es
Camil Castelo-Branco
@nl
Camil Castelo-Branco
@sl
prefLabel
Camil Castelo-Branco
@ast
Camil Castelo-Branco
@en
Camil Castelo-Branco
@es
Camil Castelo-Branco
@nl
Camil Castelo-Branco
@sl
P214
P244
P950
P1053
O-5245-2016
P106
P1580
P21
P213
0000 0004 4462 9783
P214
P244
no2006082690
P31
P3829
P496
0000-0002-9860-8318
P734
P7859
lccn-no2006082690